Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672902 | SCV000798054 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-02-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001047811 | SCV001211793 | pathogenic | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | This variant, c.5438_5443del, is a complex sequence change that results in the deletion of 3 and insertion of 1 amino acid(s) in the USH2A protein (p.Ser1813_Ser1815delinsCys). This variant is present in population databases (rs752992414, gnomAD 0.002%). This variant has been observed in individual(s) with clinical features of Usher syndrome (PMID: 32467589, 33576794; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 556843). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074368 | SCV001239944 | uncertain significance | Retinal dystrophy | 2019-07-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003472149 | SCV004200722 | likely pathogenic | Retinitis pigmentosa 39 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276247 | SCV001462255 | uncertain significance | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |